98%
921
2 minutes
20
Objectives: Dual-energy CT (DECT)-derived virtual unenhanced (VUE) images have been investigated for adrenal lesion differentiation, yet previously reported thresholds vary, hampering clinical application. We aimed to test previous VUE thresholds for adrenal lesion differentiation in a large retrospective cohort, to provide a cross-validated threshold based on our data, and to investigate the influence of underlying malignancies on differentiation accuracy.
Methods: 290 patients with 348 adrenal lesions (169 metastases, 179 adenomas) were included. Dual-layer DECT-derived VUE thresholds from 3 previous studies were retrieved, applied to our cohort and corresponding sensitivity/specificity/accuracy was calculated. Optimal threshold based on our data were determined using ROC-analysis with five-fold cross validation. Moreover, a threshold with similar specificity to the 10 HU threshold in unenhanced images was calculated. Subgroup analysis of adrenal lesion differentiation depending on underlying malignancies was performed.
Results: The previously suggested thresholds were 20, 22 and 29 HU, and corresponding sensitivity/specificity/accuracy was 0.61/0.92/0.76, 0.67/0.91/0.78, and 0.82/0.59/0.71, respectively. The threshold determined from our cohort was 24.7 HU, yielding a sensitivity/specificity/accuracy of 0.76/0.81/0.79. Differentiation in disease-specific subgroups showed similar sensitivity/specificity/accuracy (Melanoma:0.78/0.84/0.79; Lung cancer:0.78/0.8/0.78; RCC:0.78/1/0.79). The VUE threshold to achieve a 0.98 specificity similar to the unenhanced 10 HU cutoff was 17.3 HU, yielding a sensitivity of 0.49.
Conclusion: Previous VUE attenuation thresholds showed a varying accuracy for differentiation between adenomas and metastases. A cross-validated VUE threshold of 24.7 HU yielded a mean accuracy of 0.79, whereas a threshold of 17.3 HU was best for achieving comparable specificity as reported for the 10 HU threshold in unenhanced images.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s00261-025-04939-3 | DOI Listing |
Minerva Endocrinol (Torino)
September 2025
Department of Endocrinology, Karolinska University Hospital, Stockholm, Sweden -
Adrenal cysts are rare lesions that are increasingly discovered incidentally during radiological examinations conducted without suspicion of adrenal disease. Typically benign, hormonally nonfunctional, and asymptomatic, these lesions may occasionally manifest mass effect symptoms such as pain or abdominal discomfort, particularly in large cysts. Management approaches vary from no follow-up to hormonal investigation, imaging follow-up, or adrenalectomy, especially if the cyst is growing or exhibits an atypical appearance.
View Article and Find Full Text PDFCureus
August 2025
Gynaecology, Guy's and St Thomas' NHS Foundation Trust, London, GBR.
Ovarian fibromatosis (OF) is a rare, benign condition that often mimics malignancy, leading to unnecessary oophorectomies. We report the case of a 12-year-old girl presenting with acute right lower abdominal pain and vomiting, with a history of intermittent abdominal pain since age seven. Imaging revealed an enlarged, avascular right adnexa with a solid lesion.
View Article and Find Full Text PDFFront Endocrinol (Lausanne)
September 2025
Department of Infectious Disease, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Background: Paragangliomas (PGLs) are rare neuroendocrine tumors originating from the extra-adrenal autonomic paraganglia with a strong genetic background. pathogenic variants are associated with the highest rate of malignancy in PGLs. Most head and neck paragangliomas (HNPGs) are asymptomatic and benign, and multiple metastases are rare.
View Article and Find Full Text PDFJ Wildl Dis
September 2025
Division of Wildlife Conservation, Alaska Dept of Fish and Game, 1300 College Road, Fairbanks, Alaska 99701, USA.
This report describes highly pathogenic avian influenza virus (HPAI) H5N1 infections in carnivores in Alaska, US between 2022 and 2024, including a black bear (Ursus americanus), a brown bear (Ursus arctos), and the first known report of HPAI in an ermine (Mustela ermina). The two bears were cubs, and the ermine was a young adult. The black bear and ermine were euthanized after demonstrating neurologic signs, including circling, blindness, ataxia, or seizures.
View Article and Find Full Text PDFEndocrine
September 2025
Gray Faculty of Medical & Health Sciences, Tel Aviv University, Tel Aviv, Israel.